Report Detail

Other Global (United States, European Union and China) On-body Injectors Market Research Report 2019-2025

  • RnM3670065
  • |
  • 14 August, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Other

An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
In 2019, the market size of On-body Injectors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for On-body Injectors.

This report studies the global market size of On-body Injectors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the On-body Injectors production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen

Market Segment by Product Type
Electronical Injectors
Mechanical Injectors
Others

Market Segment by Application
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the On-body Injectors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key On-body Injectors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of On-body Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global On-body Injectors Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Electronical Injectors
      • 1.3.3 Mechanical Injectors
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global On-body Injectors Market Share by Application (2019-2025)
      • 1.4.2 Immuno-oncology
      • 1.4.3 Diabetes
      • 1.4.4 Cardiovascular Diseases
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global On-body Injectors Production Value 2014-2025
      • 2.1.2 Global On-body Injectors Production 2014-2025
      • 2.1.3 Global On-body Injectors Capacity 2014-2025
      • 2.1.4 Global On-body Injectors Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global On-body Injectors Market Size CAGR of Key Regions
      • 2.2.2 Global On-body Injectors Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global On-body Injectors Capacity by Manufacturers
      • 3.1.2 Global On-body Injectors Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 On-body Injectors Revenue by Manufacturers (2014-2019)
      • 3.2.2 On-body Injectors Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global On-body Injectors Market Concentration Ratio (CR5 and HHI)
    • 3.3 On-body Injectors Price by Manufacturers
    • 3.4 Key Manufacturers On-body Injectors Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into On-body Injectors Market
    • 3.6 Key Manufacturers On-body Injectors Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Electronical Injectors Production and Production Value (2014-2019)
      • 4.1.2 Mechanical Injectors Production and Production Value (2014-2019)
      • 4.1.3 Others Production and Production Value (2014-2019)
    • 4.2 Global On-body Injectors Production Market Share by Type
    • 4.3 Global On-body Injectors Production Value Market Share by Type
    • 4.4 On-body Injectors Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global On-body Injectors Consumption by Application

    6 Production by Regions

    • 6.1 Global On-body Injectors Production (History Data) by Regions 2014-2019
    • 6.2 Global On-body Injectors Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States On-body Injectors Production Growth Rate 2014-2019
      • 6.3.2 United States On-body Injectors Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States On-body Injectors Import & Export
    • 6.4 European Union
      • 6.4.1 European Union On-body Injectors Production Growth Rate 2014-2019
      • 6.4.2 European Union On-body Injectors Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union On-body Injectors Import & Export
    • 6.5 China
      • 6.5.1 China On-body Injectors Production Growth Rate 2014-2019
      • 6.5.2 China On-body Injectors Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China On-body Injectors Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 On-body Injectors Consumption by Regions

    • 7.1 Global On-body Injectors Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States On-body Injectors Consumption by Type
      • 7.2.2 United States On-body Injectors Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union On-body Injectors Consumption by Type
      • 7.3.2 European Union On-body Injectors Consumption by Application
    • 7.4 China
      • 7.4.1 China On-body Injectors Consumption by Type
      • 7.4.2 China On-body Injectors Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World On-body Injectors Consumption by Type
      • 7.5.2 Rest of World On-body Injectors Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 BD Medical
      • 8.1.1 BD Medical Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of On-body Injectors
      • 8.1.4 On-body Injectors Product Introduction
      • 8.1.5 BD Medical Recent Development
    • 8.2 Medtronic
      • 8.2.1 Medtronic Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of On-body Injectors
      • 8.2.4 On-body Injectors Product Introduction
      • 8.2.5 Medtronic Recent Development
    • 8.3 Insulet
      • 8.3.1 Insulet Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of On-body Injectors
      • 8.3.4 On-body Injectors Product Introduction
      • 8.3.5 Insulet Recent Development
    • 8.4 Sensile Medical
      • 8.4.1 Sensile Medical Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of On-body Injectors
      • 8.4.4 On-body Injectors Product Introduction
      • 8.4.5 Sensile Medical Recent Development
    • 8.5 Ypsomed
      • 8.5.1 Ypsomed Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of On-body Injectors
      • 8.5.4 On-body Injectors Product Introduction
      • 8.5.5 Ypsomed Recent Development
    • 8.6 Enable Injections
      • 8.6.1 Enable Injections Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of On-body Injectors
      • 8.6.4 On-body Injectors Product Introduction
      • 8.6.5 Enable Injections Recent Development
    • 8.7 Roche
      • 8.7.1 Roche Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of On-body Injectors
      • 8.7.4 On-body Injectors Product Introduction
      • 8.7.5 Roche Recent Development
    • 8.8 ScPharmaceuticals
      • 8.8.1 ScPharmaceuticals Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of On-body Injectors
      • 8.8.4 On-body Injectors Product Introduction
      • 8.8.5 ScPharmaceuticals Recent Development
    • 8.9 SteadyMed
      • 8.9.1 SteadyMed Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of On-body Injectors
      • 8.9.4 On-body Injectors Product Introduction
      • 8.9.5 SteadyMed Recent Development
    • 8.10 CeQur
      • 8.10.1 CeQur Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of On-body Injectors
      • 8.10.4 On-body Injectors Product Introduction
      • 8.10.5 CeQur Recent Development
    • 8.11 Tandem Diabetes Care
    • 8.12 Valeritas
    • 8.13 SteadyMed Therapeutics
    • 8.14 Amgen

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global On-body Injectors Capacity, Production Forecast 2019-2025
      • 9.1.2 Global On-body Injectors Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global On-body Injectors Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global On-body Injectors Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global On-body Injectors Production Forecast by Type
      • 9.7.2 Global On-body Injectors Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 On-body Injectors Sales Channels
      • 10.2.2 On-body Injectors Distributors
    • 10.3 On-body Injectors Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on On-body Injectors. Industry analysis & Market Report on On-body Injectors is a syndicated market report, published as Global (United States, European Union and China) On-body Injectors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of On-body Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,532.16
      3,798.24
      5,064.32
      3,014.32
      4,521.48
      6,028.64
      498,789.60
      748,184.40
      997,579.20
      276,044.80
      414,067.20
      552,089.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report